Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival

Go back to Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
(NASDAQ: RLAY) Delayed: 17.44 --0 (-0%)
Previous Close $17.44    52 Week High
Open $17.44    52 Week Low
Day High $17.44    P/E N/A 
Day Low $17.44    EPS
Volume 2,187